BioLineRx (BLRX) Receivables (2010 - 2025)
BioLineRx (BLRX) posted quarterly Receivables of $456000.0 for Q4 2025, down 88.47% year-over-year from $4.0 million in Q4 2024, and down 81.6% quarter-over-quarter from $2.5 million in Q2 2025.
Powered by 
Analysis
BioLineRx (BLRX) Receivables (2010 - 2025) Analysis & Trends
BioLineRx's Receivables history runs 6 years deep, the most recent figure standing at $456000.0 for Q4 2025.
- In Q4 2025, Receivables fell 88.47% year-over-year to $456000.0; the TTM figure through Dec 2025 stood at $456000.0 (down 88.47% YoY), while the FY2025 annual figure was $456000.0, down 88.47% from the prior year.
- Receivables for Q4 2025 stood at $456000.0, down from $2.5 million in the prior quarter.
- The five-year high for Receivables was $4.0 million in Q3 2024, with the low at $456000.0 in Q4 2025.
- The 4-year median for Receivables is $2.5 million (2025), against an average of $2.4 million.
- The sharpest annual moves came in 2024 and 2025: Receivables jumped 232.83% in 2024, then tumbled 88.47% in 2025.
- BioLineRx's Receivables stood at $721000.0 in 2022, then soared by 64.77% to $1.2 million in 2023, then surged by 232.83% to $4.0 million in 2024, then sank by 88.47% to $456000.0 in 2025.
- Business Quant data shows BLRX's Receivables at $456000.0 in Q4 2025, $2.5 million in Q2 2025, and $1.9 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 160.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.06 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 215.33 Mn |
| 10 | BioLineRx | 6.64 Bn | 6.64 Bn | 235,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 502,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 1.92 Mn |
| Dec 31, 2024 | 3.95 Mn |
| Sep 30, 2024 | 3.96 Mn |
| Jun 30, 2024 | 3.84 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 721,000.00 |
| Dec 31, 2020 | 754,000.00 |
| Dec 31, 2019 | 1.46 Mn |
| Dec 31, 2018 | 1.83 Mn |
| Dec 31, 2010 | 10.59 Mn |